Market Cap 1.07B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 3,490,300
Avg Vol 3,625,880
Day's Range N/A - N/A
Shares Out 303.16M
Stochastic %K 66%
Beta 0.85
Analysts Strong Sell
Price Target $9.17

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
JennyRowes
JennyRowes Apr. 4 at 3:36 PM
$ABSI $ABCL $RXRX $GENB absi -15% ytd, 30% short abcl +3% ytd, 22% short rxrx -26% ytd, 35% short genb +9% ytd ??? short
0 · Reply
NorthShoreTrader2021
NorthShoreTrader2021 Apr. 3 at 5:51 PM
$ABCL Zack Investment Research price forecast:
1 · Reply
8008track
8008track Apr. 2 at 9:44 PM
$ABCL still bullish. One day closer to the inevitable.
0 · Reply
Art_BunyaaHa
Art_BunyaaHa Apr. 2 at 6:49 PM
$ABCL 420
0 · Reply
Odoji
Odoji Apr. 2 at 6:41 PM
$ABCL seriously wish me luck 💉
0 · Reply
Merlintrader
Merlintrader Apr. 2 at 4:43 PM
$ABCL AbCellera Biologics (ABCL) — deep dive on platform, pipeline, cash, insiders, institutions, and what comes next https://www.merlintrader.com/abcellera-biologics-april2026/
0 · Reply
NorthShoreTrader2021
NorthShoreTrader2021 Apr. 2 at 3:34 PM
$ABCL $7 without any news possible.
1 · Reply
sogenerous
sogenerous Apr. 2 at 3:33 PM
$ABCL another push to 4-5+ soon seems likely runup into data 2nd half
4 · Reply
DragonAlgo
DragonAlgo Apr. 2 at 6:34 AM
🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2026-04-17 | Strike: $4.00 | Type: CALL Option Plan (premium): Entry: $0.11 Stop: $0.08 TP1: $0.14 TP2: $0.19 TP3: $0.26 🔗 https://dragonalgo.com
0 · Reply
tradersunion353
tradersunion353 Apr. 1 at 8:04 PM
$ABCL Looks like this will trade like this until Q4 If news are good in Q3 then this will sky rocket Otherwise we will not see s bump for next 5-10 years
1 · Reply
Latest News on ABCL
AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 5 weeks ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 5 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 5 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Biologics: Entering Growth Phase After A Pause

Oct 6, 2025, 7:35 AM EDT - 6 months ago

AbCellera Biologics: Entering Growth Phase After A Pause


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 7 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:33 PM EDT - 11 months ago

AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 11 months ago

AbCellera Reports Q1 2025 Business Results


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics: Still A Concept Stock

Dec 23, 2024, 4:39 PM EST - 1 year ago

AbCellera Biologics: Still A Concept Stock


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera: A Platform To Pipeline Transition

Oct 14, 2024, 12:04 PM EDT - 1 year ago

AbCellera: A Platform To Pipeline Transition


JennyRowes
JennyRowes Apr. 4 at 3:36 PM
$ABSI $ABCL $RXRX $GENB absi -15% ytd, 30% short abcl +3% ytd, 22% short rxrx -26% ytd, 35% short genb +9% ytd ??? short
0 · Reply
NorthShoreTrader2021
NorthShoreTrader2021 Apr. 3 at 5:51 PM
$ABCL Zack Investment Research price forecast:
1 · Reply
8008track
8008track Apr. 2 at 9:44 PM
$ABCL still bullish. One day closer to the inevitable.
0 · Reply
Art_BunyaaHa
Art_BunyaaHa Apr. 2 at 6:49 PM
$ABCL 420
0 · Reply
Odoji
Odoji Apr. 2 at 6:41 PM
$ABCL seriously wish me luck 💉
0 · Reply
Merlintrader
Merlintrader Apr. 2 at 4:43 PM
$ABCL AbCellera Biologics (ABCL) — deep dive on platform, pipeline, cash, insiders, institutions, and what comes next https://www.merlintrader.com/abcellera-biologics-april2026/
0 · Reply
NorthShoreTrader2021
NorthShoreTrader2021 Apr. 2 at 3:34 PM
$ABCL $7 without any news possible.
1 · Reply
sogenerous
sogenerous Apr. 2 at 3:33 PM
$ABCL another push to 4-5+ soon seems likely runup into data 2nd half
4 · Reply
DragonAlgo
DragonAlgo Apr. 2 at 6:34 AM
🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2026-04-17 | Strike: $4.00 | Type: CALL Option Plan (premium): Entry: $0.11 Stop: $0.08 TP1: $0.14 TP2: $0.19 TP3: $0.26 🔗 https://dragonalgo.com
0 · Reply
tradersunion353
tradersunion353 Apr. 1 at 8:04 PM
$ABCL Looks like this will trade like this until Q4 If news are good in Q3 then this will sky rocket Otherwise we will not see s bump for next 5-10 years
1 · Reply
snowPOW
snowPOW Apr. 1 at 7:29 PM
$ABCL millionaire maker... This isn't going to zero
1 · Reply
Art_BunyaaHa
Art_BunyaaHa Apr. 1 at 5:20 PM
$ABCL 420
0 · Reply
DeMampCamp
DeMampCamp Apr. 1 at 1:35 PM
1 · Reply
Rastafari
Rastafari Mar. 31 at 2:37 PM
$ABCL Paul Tudor move today?
1 · Reply
DragonAlgo
DragonAlgo Mar. 31 at 6:02 AM
🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2026-04-17 | Strike: $12.00 | Type: CALL Option Plan (premium): Entry: $0.04 Stop: $0.03 TP1: $0.05 TP2: $0.07 TP3: $0.10 Risk preset by model constraints. 🔗 https://dragonalgo.com
0 · Reply
Kaykay610
Kaykay610 Mar. 31 at 1:22 AM
$ABCL A taco wouldn't be bad right now
0 · Reply
DragonAlgo
DragonAlgo Mar. 30 at 1:49 PM
🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2026-04-17 | Strike: $3.00 | Type: CALL Option Plan (premium): Entry: $0.40 Stop: $0.29 TP1: $0.52 TP2: $0.68 TP3: $0.96 Volatility regime is active. 🔗 https://dragonalgo.com
0 · Reply
8008track
8008track Mar. 30 at 3:58 AM
$ABCL investing legend Paul Tudor Jones increases position by 1m shares in q4 2025. https://x.com/tyler_bosserman/status/2038246167440445448?s=46&t=19IS2lnKv9JueG0DGj5x7Q
1 · Reply
snowPOW
snowPOW Mar. 29 at 7:39 PM
$ABCL https://www.cnbc.com/2026/03/29/eli-lilly-reaches-deal-to-bring-ai-developed-drugs-to-global-market.html Noteworthy
0 · Reply
Biotechsleuth
Biotechsleuth Mar. 29 at 6:53 PM
$ABCL — U.S. pharmaceutical giant Eli Lilly has reached a $2.75 billion deal to bring drugs developed using artificial intelligence by Hong Kong-based Insilico Medicine to the global market.
0 · Reply
bonecrack_benny
bonecrack_benny Mar. 29 at 6:25 PM
$ABCL A lot of people are targeting $2$10 in different timelines, but the real story is bigger than that. 2026 is make-or-break for AbCellera. From here, it’s probably either close to zero or straight to the moon. And right now, AbCellera looks like a company preparing for launch. Will they fully deliver? We’ll see. But one thing feels certain: 2026 will tell the story.
1 · Reply
OwlKing
OwlKing Mar. 29 at 5:44 PM
0 · Reply